{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:17:34Z","timestamp":1784560654982,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Ipratropium bromide (IPR) and fenoterol hydrobromide (FEN) are well-known medications for treating asthma and chronic obstructive pulmonary disease (COPD). A simple, feasible, efficient, and cost-effective colorimetric assay has been established for determination of the newly introduced co-formulated metered dose inhaler (Atrovent<jats:sup>\u00ae<\/jats:sup> comp HFA). The developed method is based on the properly optimized reaction of drugs under study with the charge transfer reagent 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), resulting in orange-colored complexes measured at 464.3 and 514.0 nm for IPR and FEN, respectively. Smoothly applicable and easily manipulated resolution method, Vierordt\u2019s method, based on straightforward mathematical equations that do not need complicated software was implemented for the simultaneous determination of IPR and FEN. The proposed methodology can be applied in routine analysis enabling fast and economical determination of the combined dosage form without the need for previous separation steps. The validity of the proposed colorimetric method was thoroughly assured as per ICH guidelines with acceptable accuracy and precision. The linearity ranges for IPR and FEN were 5.0\u201355.0\u00a0\u00b5g\/mL and 10.0\u201340.0\u00a0\u00b5g\/mL, respectively. Using cutting-edge software metric tools, namely the analytical greenness (AGREE), and complementary green analytical procedure index (ComplexGAPI), the greenness profile of the suggested method was clearly evaluated. The method also conformed well to the recently published blueness (BAGI tool) and whiteness (RGB12 tool) concepts.<\/jats:p>","DOI":"10.1186\/s13065-025-01397-2","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:48:21Z","timestamp":1738993701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ecofriendly colorimetric set-up coupled with mathematical filtration strategy for simultaneous determination of ipratropium and fenoterol in their novel anti-asthmatic metered dose inhaler"],"prefix":"10.1186","volume":"19","author":[{"given":"Salma N.","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda M.","family":"Marzouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Fayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah S.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"1397_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/J.MSARD.2024.105546","volume":"85","author":"H Ghoshouni","year":"2024","unstructured":"Ghoshouni H, et al. Asthma and chronic obstructive pulmonary disease (COPD) in people with multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord. 2024;85: 105546. https:\/\/doi.org\/10.1016\/J.MSARD.2024.105546.","journal-title":"Mult Scler Relat Disord"},{"key":"1397_CR2","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1812_18","author":"S Kharbanda","year":"2021","unstructured":"Kharbanda S, Anand R. Health-related quality of life in patients with chronic obstructive pulmonary disease: a hospital-based study. Indian J Med Res. 2021. https:\/\/doi.org\/10.4103\/ijmr.IJMR_1812_18.","journal-title":"Indian J Med Res"},{"key":"1397_CR3","doi-asserted-by":"publisher","unstructured":"Bourdin A, Chenivesse C, Didier A, Touboul C, Larrousse M, Portel L. Qualas: quality of life and burden in asthma, a comparison between uncontrolled severe asthma and controlled moderate\/severe asthma; 2019. https:\/\/doi.org\/10.1183\/13993003.congress-2019.pa4251.","DOI":"10.1183\/13993003.congress-2019.pa4251"},{"key":"1397_CR4","doi-asserted-by":"publisher","DOI":"10.2196\/publichealth.9930","author":"RM Turner","year":"2018","unstructured":"Turner RM, DePietro M, Ding B. Overlap of asthma and chronic obstructive pulmonary disease in patients in the United States: analysis of prevalence, features, and subtypes. JMIR Public Health Surveill. 2018. https:\/\/doi.org\/10.2196\/publichealth.9930.","journal-title":"JMIR Public Health Surveill"},{"key":"1397_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36130","author":"PJ Barnes","year":"2008","unstructured":"Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Investig. 2008. https:\/\/doi.org\/10.1172\/JCI36130.","journal-title":"J Clin Investig"},{"key":"1397_CR6","doi-asserted-by":"crossref","unstructured":"K\u00e4ssner F, Hodder R, Bateman ED. A review of ipratropium bromide\/fenoterol hydrobromide (Berodual\u00ae) delivered via respimat \u00ae Soft MistTM inhaler in patients with asthma and chronic obstructive pulmonary disease; 2004.","DOI":"10.2165\/00003495-200464150-00005"},{"key":"1397_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.58837\/CHULA.CMJ.65.2.15","volume":"65","author":"K Kawkitinarong","year":"2021","unstructured":"Kawkitinarong K, Ananpipatkul A, Sae-Eao N, Asawawichienchinda T, Sirichana W. Effects of fenoterol\/ipratropium bromide on FEV1 and hyperinflation in Thai COPD patients. Chulalongkorn Med J. 2021;65:211\u20138. https:\/\/doi.org\/10.58837\/CHULA.CMJ.65.2.15.","journal-title":"Chulalongkorn Med J"},{"key":"1397_CR8","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2011.589837","author":"RO Salama","year":"2011","unstructured":"Salama RO, Young PM, Rogueda P, Lallement A, Iliev I, Traini D. Advances in drug delivery: is triple therapy the future for the treatment of chronic obstructive pulmonary disease? Expert Opin Pharmacother. 2011. https:\/\/doi.org\/10.1517\/14656566.2011.589837.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"1397_CR9","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1067\/mai.2000.106636","volume":"106","author":"T Katsunuma","year":"2000","unstructured":"Katsunuma T, Fujita K, Mak JCW, Barnes PJ, Ueno K, Iikura Y. \u03b2-Adrenergic agonists and bronchial hyperreactivity: role of \u03b22-adrenergic and tachykinin neurokinin-2 receptors. J Allergy Clin Immunol. 2000;106(1):S104\u20138. https:\/\/doi.org\/10.1067\/mai.2000.106636.","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl. 2","key":"1397_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000195150","volume":"50","author":"E Huhti","year":"1986","unstructured":"Huhti E, Poukkula A. Comparison of fenoterol, ipratropium bromide, and their combination in patients with asthma or chronic airflow obstruction. Respiration. 1986;50(Suppl. 2):298\u2013301. https:\/\/doi.org\/10.1159\/000195150.","journal-title":"Respiration"},{"key":"1397_CR11","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200505-047SR","author":"JF Donohue","year":"2005","unstructured":"Donohue JF. Combination therapy for chronic obstructive pulmonary disease: clinical aspects. Proc Am Thorac Soc. 2005. https:\/\/doi.org\/10.1513\/pats.200505-047SR.","journal-title":"Proc Am Thorac Soc"},{"issue":"1","key":"1397_CR12","doi-asserted-by":"publisher","first-page":"22406","DOI":"10.1038\/s41598-024-72431-x","volume":"14","author":"SN Ali","year":"2024","unstructured":"Ali SN, Saad SS, Fayed AS, Marzouk HM. Intelligent spectrophotometric resolution platforms for the challenging spectra of ipratropium and fenoterol in their combination inhaler with ecological friendliness assessment. Sci Rep. 2024;14(1):22406. https:\/\/doi.org\/10.1038\/s41598-024-72431-x.","journal-title":"Sci Rep"},{"key":"1397_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-024-01265-5","author":"SN Ali","year":"2024","unstructured":"Ali SN, Saad SS, Fayed AS, Marzouk HM. Chromatographic fingerprinting of ipratropium and fenoterol in their novel co-formulated inhaler treating major respiratory disorders; application to delivered dose uniformity testing along with greenness and whiteness assessment. BMC Chem. 2024. https:\/\/doi.org\/10.1186\/s13065-024-01265-5.","journal-title":"BMC Chem"},{"issue":"6","key":"1397_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/0731-7085(94)E0006-M","volume":"12","author":"GA Jacobson","year":"1994","unstructured":"Jacobson GA, Peterson GM. High-performance liquid chromatographic assay for the simultaneous determination of ipratropium bromide, fenoterol, salbutamol and terbutaline in nebulizer solution. J Pharm Biomed Anal. 1994;12(6):825\u201332. https:\/\/doi.org\/10.1016\/0731-7085(94)E0006-M.","journal-title":"J Pharm Biomed Anal"},{"key":"1397_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-019-0004-y","author":"HM Lotfy","year":"2019","unstructured":"Lotfy HM, Morgan EM, Fayez YM, Abdelkawy M. Different aspects in manipulating overlapped spectra used for the analysis of trimebutine maleate and structure elucidation of its degradation products. Futur J Pharm Sci. 2019. https:\/\/doi.org\/10.1186\/s43094-019-0004-y.","journal-title":"Futur J Pharm Sci"},{"key":"1397_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2023.109581","author":"HM Lotfy","year":"2024","unstructured":"Lotfy HM, El-Hanboushy S, Fayez YM, Abdelkawy M, Marzouk HM. Computational intelligence spectrophotometric scenarios for screening and quantification of single-dose triple therapy banned by the World Anti-Doping Agency in some sports. Microchem J. 2024. https:\/\/doi.org\/10.1016\/j.microc.2023.109581.","journal-title":"Microchem J"},{"key":"1397_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2020.07.030","volume-title":"Novel approaches for colorimetric measurements in analytical chemistry\u2014a review","author":"GM Fernandes","year":"2020","unstructured":"Fernandes GM, et al. Novel approaches for colorimetric measurements in analytical chemistry\u2014a review. Elsevier B.V; 2020. https:\/\/doi.org\/10.1016\/j.aca.2020.07.030."},{"key":"1397_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2021.120747","author":"A Samir","year":"2022","unstructured":"Samir A, Salem H, Abdelkawy M. Optimization of two charge transfer reactions for colorimetric determination of two beta 2 agonist drugs, salmeterol xinafoate and salbutamol, in pharmaceutical and biological samples. Spectrochim Acta A Mol Biomol Spectrosc. 2022. https:\/\/doi.org\/10.1016\/j.saa.2021.120747.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"1397_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2022.119757","author":"GH Al-Hazmi","year":"2022","unstructured":"Al-Hazmi GH, et al. Supramolecular charge-transfer complex generated by the interaction between tin(II) 2,3-naphtalocyanine as a donor with DDQ as an acceptor: Spectroscopic studies in solution state and theoretical calculations. J Mol Liq. 2022. https:\/\/doi.org\/10.1016\/j.molliq.2022.119757.","journal-title":"J Mol Liq"},{"key":"1397_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharma.2020.04.002","author":"MM Baker","year":"2020","unstructured":"Baker MM, El-Kafrawy DS, Abdel-Khalek MM, Belal TS. Validated spectrophotometric determination of maduramicin ammonium using three charge transfer complexation reactions. Ann Pharm Fr. 2020. https:\/\/doi.org\/10.1016\/j.pharma.2020.04.002.","journal-title":"Ann Pharm Fr"},{"key":"1397_CR21","volume-title":"The stationary office","author":"British Pharmacopoeia","year":"2022","unstructured":"British Pharmacopoeia. The stationary office, vol. II. British Pharmacopoeia; 2022."},{"key":"1397_CR22","first-page":"735","volume":"34","author":"K Basavaiah","year":"2011","unstructured":"Basavaiah K, Zenita O. Spectrophotometric determination of famotidine using sulphonphthalein dyes. Quim Nova. 2011;34:735\u201342.","journal-title":"Quim Nova"},{"key":"1397_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.scp.2022.100806","author":"S El-Hanboushy","year":"2022","unstructured":"El-Hanboushy S, Marzouk HM, Fayez YM, Abdelkawy M, Lotfy HM. Sustainable spectrophotometric determination of antihypertensive medicines reducing COVID-19 risk via paired wavelength data processing technique\u2014assessment of purity, greenness and whiteness. Sustain Chem Pharm. 2022. https:\/\/doi.org\/10.1016\/j.scp.2022.100806.","journal-title":"Sustain Chem Pharm"},{"key":"1397_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2023.123650","volume":"307","author":"Y Rostom","year":"2024","unstructured":"Rostom Y, Rezk MR, Wadie M, Abdel-Moety EM, Marzouk HM. State-of-the-art mathematically induced filtration approaches for smart spectrophotometric assessment of silodosin and solifenacin mixture in their new challenging formulation: multi-tool greenness and whiteness evaluation. Spectrochim Acta A Mol Biomol Spectrosc. 2024;307: 123650. https:\/\/doi.org\/10.1016\/j.saa.2023.123650.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"1397_CR25","doi-asserted-by":"publisher","DOI":"10.1134\/S1061934823090083","author":"HM Marzouk","year":"2023","unstructured":"Marzouk HM, Ayish NS, El-Zeany BA, Fayed AS. Green spectrophotometric resolution platforms of spectrally overlapping signals of antihypertensive ternary pharmaceutical formulation: application to content uniformity testing. J Anal Chem. 2023. https:\/\/doi.org\/10.1134\/S1061934823090083.","journal-title":"J Anal Chem"},{"key":"1397_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2022.121523","author":"S El-Hanboushy","year":"2022","unstructured":"El-Hanboushy S, Marzouk HM, Fayez YM, Abdelkawy M, Lotfy HM. Eco-friendly spectrophotometric evaluation of triple-combination therapies in the treatment strategy of patients suffering from hypertension during coronavirus pandemic\u2014spectralprint recognition study. Spectrochim Acta A Mol Biomol Spectrosc. 2022. https:\/\/doi.org\/10.1016\/j.saa.2022.121523.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"1397_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2022.121036","author":"SS Saleh","year":"2022","unstructured":"Saleh SS, Lotfy HM, Tiris G, Erk N, El-Naem OA. The power of High Impact Amplitude Manipulation (HIAM) technique for extracting the basic spectra of two fixed-dose combinations (FDC)\u2014spectrophotometric purity analysis via spectral contrast angle. Spectrochim Acta A Mol Biomol Spectrosc. 2022. https:\/\/doi.org\/10.1016\/j.saa.2022.121036.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"1397_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15260","author":"Z Kayali","year":"2023","unstructured":"Kayali Z, Obaydo RH, Alhaj SA. Spider diagram and sustainability evaluation of UV-methods strategy for quantification of aspirin and sildenafil citrate in the presence of salicylic acid in their bulk and formulation. Heliyon. 2023. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15260.","journal-title":"Heliyon"},{"issue":"2","key":"1397_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jpha.2013.06.003","volume":"4","author":"HH Eldaroti","year":"2014","unstructured":"Eldaroti HH, Gadir SA, Refat MS, Adam AMA. Charge-transfer interaction of drug quinidine with quinol, picric acid and DDQ: spectroscopic characterization and biological activity studies towards understanding the drug-receptor mechanism. J Pharm Anal. 2014;4(2):81\u201395. https:\/\/doi.org\/10.1016\/j.jpha.2013.06.003.","journal-title":"J Pharm Anal"},{"key":"1397_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.131795","author":"FZ Hamamdia","year":"2022","unstructured":"Hamamdia FZ, Messiad H, Belguidoum K, Lemouari N, Amira-Guebailia H. Synthesis, spectroscopic and thermodynamic study of charge transfer complexes of natural drug rutin as donor with \u03a0-acceptors; 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and tetracyanoethylene. J Mol Struct. 2022. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131795.","journal-title":"J Mol Struct"},{"issue":"2","key":"1397_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.52711\/2231-5675.2022.00026","volume":"12","author":"AJ Vyas","year":"2022","unstructured":"Vyas AJ, Jha SA, Patel AB, Patel A, Shah SR, Sheth DB. Review on simultaneous equation method (Vierodt\u2019s Method). Asian J Pharm Anal. 2022;12(2):149\u201356. https:\/\/doi.org\/10.52711\/2231-5675.2022.00026.","journal-title":"Asian J Pharm Anal"},{"key":"1397_CR32","unstructured":"El-Malla S, Kamal A, Hammad S, Kamal AH, El-Malla SF, Hammad SF. A review on UV spectrophotometric methods for simultaneous multicomponent analysis. Eur J Pharm Med Res. 2016. www.ejpmr.com. Accessed 06 May 2024."},{"key":"1397_CR33","unstructured":"Mashru RC, Gondalia R, Mashru R, Savaliya P. Development and validation of spectrophotometric methods for simultaneous estimation of IBUPROFEN and PARACETAMOL in soft gelatin capsule by simultaneous equation method. https:\/\/www.researchgate.net\/publication\/228791463"},{"key":"1397_CR34","volume-title":"Guidelines, validation of analytical procedures: text and methodology, Q2 (R1)","author":"International Council for Harmonisation (ICH)","year":"2005","unstructured":"International Council for Harmonisation (ICH). Guidelines, validation of analytical procedures: text and methodology, Q2 (R1). International Council for Harmonisation; 2005."},{"issue":"6","key":"1397_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.trac.2008.05.003","volume":"27","author":"S Armenta","year":"2008","unstructured":"Armenta S, Garrigues S, de la Guardia M. Green analytical chemistry. TrAC Trends Anal Chem. 2008;27(6):497\u2013511. https:\/\/doi.org\/10.1016\/j.trac.2008.05.003.","journal-title":"TrAC Trends Anal Chem"},{"issue":"13","key":"1397_CR36","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1039\/c6gc00611f","volume":"18","author":"CM Alder","year":"2016","unstructured":"Alder CM, et al. Updating and further expanding GSK\u2019s solvent sustainability guide. Green Chem. 2016;18(13):3879\u201390. https:\/\/doi.org\/10.1039\/c6gc00611f.","journal-title":"Green Chem"},{"key":"1397_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24761-x","author":"C Larsen","year":"2021","unstructured":"Larsen C, et al. A tool for identifying green solvents for printed electronics. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/s41467-021-24761-x.","journal-title":"Nat Commun"},{"issue":"14","key":"1397_CR38","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE\u2014analytical GREEnness metric approach and software. Anal Chem. 2020;92(14):10076\u201382. https:\/\/doi.org\/10.1021\/acs.analchem.0c01887.","journal-title":"Anal Chem"},{"key":"1397_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2022.121063","author":"Y Rostom","year":"2022","unstructured":"Rostom Y, Wadie M, Rezk MR, Marzouk HM, Abdel-Moety EM. Fingerprinting and iso-absorptive resolution techniques for the spectrally overlapping Dutasteride and Silodosin mixture: content uniformity testing along with greenness profile assessment. Spectrochim Acta A Mol Biomol Spectrosc. 2022. https:\/\/doi.org\/10.1016\/j.saa.2022.121063.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"1397_CR40","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/J.TALANTA.2018.01.013","volume":"181","author":"J P\u0142otka-Wasylka","year":"2018","unstructured":"P\u0142otka-Wasylka J. A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index. Talanta. 2018;181:204\u20139. https:\/\/doi.org\/10.1016\/J.TALANTA.2018.01.013.","journal-title":"Talanta"},{"issue":"21","key":"1397_CR41","doi-asserted-by":"publisher","first-page":"8657","DOI":"10.1039\/d1gc02318g","volume":"23","author":"J P\u0142otka-Wasylka","year":"2021","unstructured":"P\u0142otka-Wasylka J, Wojnowski W. Complementary green analytical procedure index (ComplexGAPI) and software. Green Chem. 2021;23(21):8657\u201365. https:\/\/doi.org\/10.1039\/d1gc02318g.","journal-title":"Green Chem"},{"key":"1397_CR42","doi-asserted-by":"publisher","DOI":"10.1039\/d3gc02347h","author":"N Manousi","year":"2023","unstructured":"Manousi N, Wojnowski W, P\u0142otka-Wasylka J, Samanidou V. Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality. Green Chem. 2023. https:\/\/doi.org\/10.1039\/d3gc02347h.","journal-title":"Green Chem"},{"key":"1397_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.scp.2023.101294","author":"MA El Hamd","year":"2023","unstructured":"El Hamd MA, et al. Roth\u2019s switch-on fluoremetric probe for green tracking and quantifying of 1.4-dihydropyridine medication: evaluation of greenness, whiteness, and blueness. Sustain Chem Pharm. 2023. https:\/\/doi.org\/10.1016\/j.scp.2023.101294.","journal-title":"Sustain Chem Pharm"},{"key":"1397_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2021.116223","volume-title":"White Analytical Chemistry: an approach to reconcile the principles of Green Analytical Chemistry and functionality","author":"PM Nowak","year":"2021","unstructured":"Nowak PM, Wietecha-Pos\u0142uszny R, Pawliszyn J. White Analytical Chemistry: an approach to reconcile the principles of Green Analytical Chemistry and functionality. Elsevier B.V; 2021. https:\/\/doi.org\/10.1016\/j.trac.2021.116223."},{"key":"1397_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-023-01015-z","author":"HM Marzouk","year":"2023","unstructured":"Marzouk HM, El-Hanboushy S, Obaydo RH, Fayez YM, Abdelkawy M, Lotfy HM. Sustainable chromatographic quantitation of multi-antihypertensive medications: application on diverse combinations containing hydrochlorothiazide along with LC\u2013MS\/MS profiling of potential impurities: greenness and whiteness evaluation. BMC Chem. 2023. https:\/\/doi.org\/10.1186\/s13065-023-01015-z.","journal-title":"BMC Chem"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01397-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01397-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01397-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:48:26Z","timestamp":1738993706000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01397-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1397"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01397-2","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}